19.07.2022 • News

STAXS Starts Construction of Dedicated Carbon Neutral Facility to Meet Increased Customer Needs

To further increase its capabilities in serving Life Science customers in Europe, STAXS is expanding its facility in Heerenveen, specifically designed for this customer segment and with carbon neutrality in mind.

With this expansion, the capacity of the facility will roughly double in size, and allow STAXS to continue to innovate and grow in a sustainable way in the future. The new expansion allows STAXS  to continue to provide quality services to a rapidly expanding customer base.

Green energy use and reducing CO2 emissions
The current facility already uses green energy and with this expansion, all of the warehouse will be heated without the use of fossil fuels. The lack of grid capacity was a challenging factor in the process, as STAXS was dedicated to have this building operating without fossil fuels. STAXS is grateful to her partners, including the city of Heerenveen, who have all supported the project. Through their combined efforts, it is now possible to connect the building onto the electricity grid and realize STAXS CO2 reduction goals.

The expansion of the STAXS facility is an example of an energy neutral and inspiring environment and the next big step for STAXS to reach CO2 neutrality. The construction work has started in June and is expected to be finalized in Q1 2023.

STAXS Starts Construction of Dedicated Carbon Neutral Facility to Meet...

Company

Logo:

STAXS Belgium NV.

Tunnelweg 20
2845 Niel
Belgium

Company contact







Interview

The UK Chemical Supply Chain
Trade and Competitiveness

The UK Chemical Supply Chain

The CBA, led by CEO Tim Doggett, is steering the UK chemical supply chain through trade uncertainty, sustainability pressures and logistics challenges, as he explains in this interview with CHEManager.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read